DOYLE JOHN C 4

4 · CASTLIGHT HEALTH, INC. · Filed May 17, 2019

Form 4

Period: 2019-05-15

CFO, V.P. & Treasurer

Transactions

Exercise/Conversion
Class B Common Stock
2019-05-15+8,250→ 312,380 total
Sale
Class B Common Stock
2019-05-16$3.62/sh−2,877$10,421→ 309,503 total
Exercise/Conversion
Restricted Stock Units
2019-05-15−8,250→ 0 total
Exercise: $0.00→ Class B Common Stock (8,250 underlying)

Footnotes (5)

[F1]Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on June 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 4.
[F2]Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
[F3]Represents the weighted average sales price per share. The shares sold at prices ranging from $3.60 to $3.63 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
[F4]Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.
[F5]The RSUs vest over 4 years as follows: 25% of the RSUs vested on May 15, 2016 and the remainder will vest on each quarterly anniversary thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting.

Documents

1 file